Stempeutics has got DCGI approval for stem cell based product
Stempeutics Research has got the limited approval from the national drug regulator, DCGI, for its stem cell based product Stempeucel to treat Buerger’s Disease. Cipla,...
Download Unicorn Signals App
Powered By EquityPandit
